Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP508356.RAQslkjr4YXXvoSEcr5wkF0IudHopvdrutSPCxyD75dm8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP508356.RAQslkjr4YXXvoSEcr5wkF0IudHopvdrutSPCxyD75dm8130_assertion type Assertion NP508356.RAQslkjr4YXXvoSEcr5wkF0IudHopvdrutSPCxyD75dm8130_head.
- NP508356.RAQslkjr4YXXvoSEcr5wkF0IudHopvdrutSPCxyD75dm8130_assertion wasGeneratedBy ECO_0000203 NP508356.RAQslkjr4YXXvoSEcr5wkF0IudHopvdrutSPCxyD75dm8130_provenance.
- NP508356.RAQslkjr4YXXvoSEcr5wkF0IudHopvdrutSPCxyD75dm8130_assertion wasDerivedFrom befree-2016 NP508356.RAQslkjr4YXXvoSEcr5wkF0IudHopvdrutSPCxyD75dm8130_provenance.
- NP508356.RAQslkjr4YXXvoSEcr5wkF0IudHopvdrutSPCxyD75dm8130_assertion SIO_000772 16093797 NP508356.RAQslkjr4YXXvoSEcr5wkF0IudHopvdrutSPCxyD75dm8130_provenance.
- NP508356.RAQslkjr4YXXvoSEcr5wkF0IudHopvdrutSPCxyD75dm8130_assertion evidence source_evidence_literature NP508356.RAQslkjr4YXXvoSEcr5wkF0IudHopvdrutSPCxyD75dm8130_provenance.
- NP508356.RAQslkjr4YXXvoSEcr5wkF0IudHopvdrutSPCxyD75dm8130_assertion description "[Liposomal encapsulation of doxorubicin when substituted for doxorubicin in the CHOP regimen (cyclophosphamide, doxorubicin, vincristine, prednisone) seems to overcome P-glycoprotein-mediated drug resistance in AIDS-related lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP508356.RAQslkjr4YXXvoSEcr5wkF0IudHopvdrutSPCxyD75dm8130_provenance.